Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 ACHIEVE-2 and ACHIEVE-5 trials. ACHIEVE-2, the second head-to-head trial in the program, evaluated orforglipron versus dapagliflozin, an SGLT-2 inhibitor, in adults with type 2 diabetes inadequately controlled on metformin.

Liver cancer remains one of the worlds most lethal cancers, ranking as the third leading cause of cancer-related deaths. Although surgical advances have improved safety, recurrence after hepatectomy continues to be a major challenge.

Since ancient times, it was thought that painful stomach ulcers were caused by eating spicy foods or having an unhealthy diet. But since then, researchers have found that Helicobacter pylori a common bacterium found in over 60% of the world’s population—was the real culprit behind most stomach ulcers and a high risk for stomach cancer.

First-class B.Tech / B.Pharma / B.Sc / M.Sc / M.Tech. / M.Pharm. / M.V.Sc./ or equivalent in relevant discipline with high academic attainment, with first class in graduate examination and post-graduate examination.

Pharm.D / Bachelors Degree / Nursing / B. Sc / M. Sc. Prior experience in research preferred. Must be proficient in English,Preferably familiar with Kannada / Tamil / Telugu.

Masters in Natural or Agricultural or Pharmaceutical Sciences / MVSc / Animal Sciences OR Bachelors degree in Engineering or Technology or Medicine from a recognized University

Masters Degree in Natural or Agricultural Sciences / MVSc or Bachelors Degree in Engineering or Technology or Medicine from a recognized University or equivalent

Completed MSc / equivalent in any branch of Life Sciences with CRISPR / Cas9 based genome engineering, cell and molecular biology experience. With 2 years of experience.

First class Post Graduate Degree, including the integrated. PG Degrees. Second class Post Graduate Degree, including the integrated PG Degrees with PhD

Ph.D. in Animal Sciences / Veterinary sciences / Life sciences. Candidate having experience in transcriptional / epigenetic regulation of metabolite or protein regulation, selection of aptamers, generation of monoclonal antibodies will be preferred. 

Experience in review of HPLC, GC, LCMS calibration data & Analytical Data review &Review of Analytical Method Validations, Method Transfers, Protocols & Reports.

Able to perform Biochemical techniques, Chromatography techniques, Electrophoresis techniques, Immuno assay techniques, Cell culture techniques and Molecular techniques

Responsible for writing technical documents, including method development reports, validation protocols, and regulatory submissions.

Processing activities include assessing case validity, undertaking duplicate checks, creating cases in the database, prioritizing cases as per company guidance

Perform and document scientific experiments in the laboratory for drug substances and drug products in collaboration with multifunctional project teams. Contribute to maintenance of lab instruments / day-to-day operations.

You will be responsible for the promotion of the new product. You will be executing the Product Management Team’s marketing strategy, analysing market trends, consulting with doctors on new product potential, and relaying feedback to the Product Management Team.

Establish and maintain peer-level relationships with oncology Key Opinion Leaders (KOLs) across academic and private institutions.

Drive process improvements and system enhancements to optimize the use of Veeva Vault for Quality Management. Support the implementation and ongoing maintenance of Veeva Vault Quality modules aligned with regulatory and business needs.

In the ever-evolving world of cosmetics, stick formulations are rapidly gaining traction among beauty enthusiasts and professionals alike. These compact, travel-friendly products cater to the growing demand for convenient beauty routines, allowing for easy touch-ups and quick applications, especially during busy mornings.